CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Empower Neuromodulation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03983317
NCT03983317N/ACompleted
CompareCT.gov

Pilot Evaluation of the Empower Neuromodulation System in Alcohol Use Disorder (AUD) Patients

Theranova, L.L.C.·interventional·Posted Jun 12, 2019·Updated Nov 18, 2020

In Brief

A clinical study evaluating Empower Neuromodulation System for Alcohol Use Disorder. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This study evaluates the effects of peripheral nerve stimulation on alcohol craving and consumption in participants with alcohol use disorder (AUD). This is a pilot investigation in which all participants will receive the active treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA), Northern California Institute of Research and Education

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 12, 2019
Enrollment StartMay 20, 2019
Primary CompletionMar 26, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.1 years ago

Interventions

Empower Neuromodulation Systemdevice

Transcutaneous electrical nerve stimulation